Ensysce Biosciences, Inc. (ENSC)

Ensysce Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019	2018	2017
Cash & Equivalents	1.12	3.15	12.26	0.19	0.34	1.66	2.09
Cash & Cash Equivalents	1.12	3.15	12.26	0.19	0.34	1.66	2.09
Cash Growth	-64.30%	-74.34%	6215.06%	-43.14%	-79.41%	-20.65%	-
Receivables	0.1	0.28	0.44	0	0.17	0	0
Other Current Assets	1.07	1.87	2.96	0.15	0.1	0.26	0.22
Total Current Assets	2.29	5.3	15.66	0.35	0.62	1.92	2.31
Property, Plant & Equipment	0	0.03	0.02	0.02	0	0	0
Long-Term Investments	0	0	0	0	0	202.92	200.12
Other Long-Term Assets	0.42	0.56	0.73	-0.02	0.01	0	0
Total Long-Term Assets	0.42	0.59	0.75	0	0.01	202.92	200.12
Total Assets	2.71	5.89	16.42	0.35	0.62	204.83	202.43
Accounts Payable	1.94	2.94	0.3	1.72	0.54	0.43	0.11
Current Debt	0.85	4.29	12.77	4.27	2.62	0	0
Other Current Liabilities	0.54	2.23	3.41	1.02	4.14	0.01	0.04
Total Current Liabilities	3.33	9.46	16.48	7.01	7.3	0.44	0.16
Long-Term Debt	0	0.14	4.44	0	0	0	0
Other Long-Term Liabilities	0.03	0.31	3.65	0	0	7	7
Total Long-Term Liabilities	0.03	0.45	8.09	0	0	7	7
Total Liabilities	3.36	9.91	24.58	7.01	7.3	7.44	7.16
Total Debt	0.85	4.43	17.21	4.27	2.62	0	0
Debt Growth	-80.72%	-74.24%	303.08%	62.91%	-	-	-
Retained Earnings	-121.56	-110.93	-85.85	-55.96	-56.02	2.09	-0.03
Shareholders' Equity	-0.32	-3.71	-7.88	-6.44	-6.68	5	5
Net Cash / Debt	0.27	-1.29	-4.95	-4.08	-2.28	1.66	2.09
Net Cash / Debt Growth	-	-	-	-	-	-20.65%	-
Net Cash Per Share	0.12	-7.15	-58.91	-59.27	-21.98	66.31	81.11
Working Capital	-1.04	-4.17	-0.82	-6.66	-6.68	1.48	2.15
Book Value Per Share	-0.14	-20.64	-93.77	-98.03	-64.37	199.91	194.03

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).